tirzepatide or mounjaro (tirzepatide) Doses & Titration What to know about Mounjaro,

10.2337/db14-0976 Diabetes 22 KrasnerN

Maxwell felt she had lost part of her identity when she was seen first as the fat person. Losing weight finally let her be seen as herselfas Cassiebut would regaining it erase a part of her identity again

Now I think people will say it was because of the fat loss

Liraglutide, semaglutide and tirzepatide are incretin-based therapies currently approved by FDA for the management of obesity, while triple GIPR/GCGR/GLP-1R agonist retatrutide (LY3437943), the cagrilintide/semaglutide (CagriSema) 2.4 mg combination, high-dose oral semaglutide, and oral orforglipron are in advanced stages of development